New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 17, 2014
10:03 EDTALDW, KOG, AGU, RNF, POT, PSA, WTS, TCP, SI, STAA, REGN, POST, PTEN, MMLP, LO, CVLT, BHI, AHT, SAPOn The Fly: Analyst Upgrade Summary
Alon USA Partners (ALDW) upgraded to Buy from Neutral at Citigroup... Ashford Hospitality (AHT) upgraded to Outperform from Market Perform at JMP Securities... Baker Hughes (BHI) upgraded to Buy from Neutral at Goldman... CommVault (CVLT) upgraded to Buy from Neutral at Mizuho... Lorillard (LO) upgraded to Buy from Neutral at Goldman... Martin Midstream Partners (MMLP) upgraded to Buy from Neutral at UBS... Patterson-UTI Energy (PTEN) upgraded to Conviction Buy from Neutral at Goldman... Post Holdings (POST) upgraded to Buy from Neutral at SunTrust... Regeneron (REGN) upgraded to Buy from Neutral at Citigroup... STAAR Surgical (STAA) upgraded to Buy from Hold at Canaccord... Siemens (SI) upgraded to Buy from Neutral at BofA/Merrill... TC PipeLines (TCP) upgraded to Buy from Neutral at UBS... Watts Water (WTS) upgraded to Buy from Hold at BB&T... Public Storage (PSA) upgraded to Outperform from Neutral at Macquarie... Potash (POT) upgraded to Market Perform from Underperform at Cowen... Rentech Nitrogen (RNF) upgraded to Market Perform from Underperform at Cowen... Agrium (AGU) upgraded to Market Perform from Underperform at Cowen... Kodiak Oil & Gas (KOG) upgraded to Buy from Accumulate at KLR Group... SAP (SAP) upgraded to Buy from Neutral at Citigroup.
News For ALDW;AHT;BHI;CVLT;LO;MMLP;PTEN;POST;REGN;STAA;SI;TCP;WTS;PSA;POT;RNF;AGU;KOG;SAP From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | all recent news | >>
October 21, 2014
07:11 EDTLOReynolds American says responding to second request from FTC regarding Lorillard
Subscribe for More Information
06:04 EDTPOSTPost Holdings upgraded to Buy from Neutral at Goldman
Goldman upgraded Post Holdings to Buy due to compelling valuation, earnings power, cost cutting initiatives, and expectations for a resumption in M&A. Price target raised to $44 from $42.
October 20, 2014
12:09 EDTSAPIBM hits 52 week low after earnings miss, 2015 profit target dropped
Subscribe for More Information
10:38 EDTSAPHigh option volume stocks
Subscribe for More Information
08:44 EDTSAPIBM CEO says recent Apple, SAP deals represent change in partnering strategy
Subscribe for More Information
07:16 EDTSTAA, REGNAmerican Academy of Ophthalmology to hold annual meeting
AAO Annual Meeting 2014 is being held in Chicago on October 18-21.
07:12 EDTSICongress of Neurological Surgeons to hold annual meeting
Subscribe for More Information
07:11 EDTSIAmerican Society for Reproductive Medicine to hold annual meeting
2014 Annual Meeting of ASRM is being held in Honolulu on October 18-22.
07:10 EDTREGNAmerican Society of Human Genetics to hold annual meeting
Subscribe for More Information
07:02 EDTREGNRegeneron Sanofi begins dosing in Phase 3 study of dupilumab
Regeneron Pharmaceuticals (REGN) and Sanofi (SNY) announced that the first patients have been dosed in a Phase 3 clinical study of dupilumab, an investigational therapy that blocks IL-4 and IL-13 signaling, in adults with moderate-to-severe atopic dermatitis, or AD, that is not adequately controlled with topical AD medications. LIBERTY AD CHRONOS, the first trial in the Phase 3 clinical program for dupilumab, is a randomized, double-blind, placebo-controlled, multi-national study with the primary objective of demonstrating the efficacy of dupilumab in adults with moderate to severe AD when administered concomitantly with topical corticosteroids through 16 weeks.
05:23 EDTSAPSAP cuts FY14 operating profit view to EUR 5.6B-EUR 5.8B from EUR 5.8B-EUR 6B
Subscribe for More Information
05:16 EDTSAPSAP reports Q3 Non-IFRS EPS EUR 0.84 vs EUR 0.78 last year
Subscribe for More Information
October 19, 2014
13:03 EDTPOSTPost Holdings shares look attractive, Barron's says
Subscribe for More Information
October 17, 2014
13:03 EDTBHIBaker Hughes reports U.S. rig count down 12 from last week to 1918
Subscribe for More Information
10:00 EDTPTENOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: AK Steel (AKS) upgraded to Buy from Neutral at Nomura... AMD (AMD) upgraded to Sector Perform from Underperform at Pacific Crest... Atlantic Power (AT) upgraded to Market Perform from Underperform at BMO Capital... Basic Energy (BAS) upgraded to Outperform from Market Perform at Cowen... BorgWarner (BWA) upgraded to Buy from Hold at Deutsche Bank... CA Technologies (CA) upgraded to Overweight from Equal Weight at Barclays... Calumet Specialty Products (CLMT) upgraded to Outperform at Wells Fargo... DHT Holdings (DHT) upgraded to Buy from Hold at Evercore... Exelon (EXC) upgraded to Neutral from Sell at Citigroup... Fifth Third Bancorp (FITB) upgraded to Buy from Neutral at Citigroup... Goldman Sachs (GS) upgraded to Outperform from Market Perform at Keefe Bruyette... Helmerich & Payne (HP) upgraded to Buy from Neutral at UBS... Hilton (HLT) upgraded to Buy from Neutral at SunTrust... Hyatt Hotels (H) upgraded to Outperform from Neutral at Macquarie... IPG Photonics (IPGP) upgraded at Stifel... ITC Holdings (ITC) upgraded to Neutral from Underperform at Credit Suisse... Manpower (MAN) upgraded to Outperform from Market Perform at Avondale... Nabors Industries (NBR) upgraded to Outperform from Market Perform at Cowen... Newpark Resources (NR) upgraded at Cowen... Old Dominion (ODFL) upgraded to Buy from Neutral at Longbow... PDC Energy (PDCE) upgraded at SunTrust... Patterson-UTI (PTEN) upgraded to Buy from Neutral at UBS... PrivateBancorp (PVTB) upgraded to Outperform from Neutral at Macquarie... QLogic (QLGC) upgraded to Buy from Hold at Summit Research... RPC, Inc. (RES) upgraded at Cowen... Sonoco (SON) upgraded to Neutral from Underperform at DA Davidson... Southwestern Energy (SWN) upgraded to Outperform from Market Perform at Raymond James... SunEdison (SUNE) upgraded to Outperform at Cowen... TSMC (TSM) upgraded to Buy from Neutral at Mizuho... Tesco (TESO) upgraded to Outperform from Market Perform at Cowen... UnitedHealth (UNH) upgraded to Outperform from Market Perform at Leerink... Xilinx (XLNX) upgraded to Outperform from Market Perform at Wells Fargo.
09:06 EDTREGNAmgen files patent infringement lawsuit against Sanofi, Regeneron
Amgen (AMGN) announced that it filed a lawsuit in the United States District Court of Delaware against Sanofi (SNY), Aventisub, formerly doing business as Aventis Pharmaceuticals, and Regeneron Pharmaceuticals (REGN) for patent infringement of U.S. Patent Numbers 8,563,698, 8,829,165, and 8,859,741. These patents, which are owned by Amgen, describe and claim monoclonal antibodies to proprotein convertase subtilisin/kexin type 9, or PCSK9. By its complaint, Amgen seeks an injunction to prevent the infringing manufacture, use and sale of Sanofi and Regeneron's alirocumab, a monoclonal antibody targeting PCSK9. Sanofi and Regeneron recently announced that they have completed Phase 3 clinical trials on alirocumab and intend to pursue regulatory approval to market alirocumab in the U.S. Amgen previously announced submission of a Biologics License Application to the FDA for evolocumab, its own investigational human monoclonal antibody to PCSK9, for the treatment of high cholesterol, on Aug. 28.
08:26 EDTBHICredit Suisse says its time to buy Baker Hughes
Credit Suisse believes Baker Hughes shares are "washed out" and believes its time to buy shares. The analyst is confident it can hit Q4 consensus EPS estimate of $1.26 given strength in pumping and any improvement in the Gulf of Mexico. Shares are Outperform rated with an $81 price target and $97 price target.
07:34 EDTBHIBaker Hughes maintains positive outlook despite uncertainty, says UBS
Subscribe for More Information
07:07 EDTREGNRegeneron announces EYLEA results from NIH study
Subscribe for More Information
06:25 EDTPTENPatterson-UTI upgraded to Buy from Neutral at UBS
Subscribe for More Information
1 | 2 | 3 | 4 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use